These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6109076)

  • 1. Acute phase proteins in systemic sclerosis.
    Bayston R
    Lancet; 1981 Jan; 1(8210):43. PubMed ID: 6109076
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute phase proteins in systemic sclerosis.
    Whicher JT; Martin MF; Dieppe PA
    Lancet; 1981 Feb; 1(8215):329. PubMed ID: 6109967
    [No Abstract]   [Full Text] [Related]  

  • 3. Absence of prostaglandin stimulated increase in acute phase proteins in systemic sclerosis.
    Whicher JT; Martin MF; Dieppe PA
    Lancet; 1980 Nov; 2(8205):1187-8. PubMed ID: 6107783
    [No Abstract]   [Full Text] [Related]  

  • 4. Labour-associated increase in C-reactive protein concentration is not predictive of postpartum relapse activity among mothers with multiple sclerosis.
    Jalkanen A; Kauko T; Koskinen JO; Waris ME; Airas L
    Mult Scler; 2014 Nov; 20(13):1790-1. PubMed ID: 24696054
    [No Abstract]   [Full Text] [Related]  

  • 5. High sensitivity measurement of CRP and disease progression in multiple sclerosis.
    Soilu-Hänninen M; Koskinen JO; Laaksonen M; Hänninen A; Lilius EM; Waris M
    Neurology; 2005 Jul; 65(1):153-5. PubMed ID: 16009907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin A and systemic inflammation as protective factors in multiple sclerosis.
    Salzer J; Hallmans G; Nyström M; Stenlund H; Wadell G; Sundström P
    Mult Scler; 2013 Jul; 19(8):1046-51. PubMed ID: 23334316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The significance of C-reactive protein determination in the diagnosis and evaluation of the clinical course of multiple sclerosis].
    Hrazdira CL; Zouhar A; Polcáková M
    Cesk Neurol Neurochir; 1980 Sep; 43(5):290-5. PubMed ID: 7418055
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biochemical data in multiple sclerosis].
    Khondkarian OA; Larskiĭ EG; Bauman LK; Galuzo NV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(12):1769-76. PubMed ID: 6000476
    [No Abstract]   [Full Text] [Related]  

  • 9. [Increased plasma C-reactive protein in a pregnant woman with multiple sclerosis: corticotherapy or not ?].
    Limelette A; Caucheteux N; Ramont L; Tourbah A; Maquart FX
    Ann Biol Clin (Paris); 2010; 68(2):243-7. PubMed ID: 20348053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there an association between the Expanded Disability Status Scale and inflammatory markers in multiple sclerosis?
    Guzel I; Mungan S; Oztekin ZN; Ak F
    J Chin Med Assoc; 2016 Feb; 79(2):54-7. PubMed ID: 26589195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis.
    Shu Y; Li R; Qiu W; Chang Y; Sun X; Fang L; Chen C; Yang Y; Lu Z; Hu X; Kermode AG
    Mult Scler Relat Disord; 2017 Nov; 18():65-70. PubMed ID: 29107207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences with cytostatic agents in multiple sclerosis].
    Danielczyk W
    Wien Klin Wochenschr; 1970 Oct; 82(40):697-9. PubMed ID: 5522091
    [No Abstract]   [Full Text] [Related]  

  • 13. Cannabinoid influence on cytokine profile in multiple sclerosis.
    Katona S; Kaminski E; Sanders H; Zajicek J
    Clin Exp Immunol; 2005 Jun; 140(3):580-5. PubMed ID: 15932522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRM assay for quantitation of complement components in human blood plasma - a feasibility study on multiple sclerosis.
    Rezeli M; Végvári A; Ottervald J; Olsson T; Laurell T; Marko-Varga G
    J Proteomics; 2011 Dec; 75(1):211-20. PubMed ID: 21703369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-centrifuge studies of lipoproteins in multiple sclerosis.
    AIRD RB; GOFMAN JW; JONES HB; CAMPBELL B; GAROUTTE B
    Neurology; 1953 Jan; 3(1):22-34. PubMed ID: 13013495
    [No Abstract]   [Full Text] [Related]  

  • 16. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.
    Moreau T; Coles A; Wing M; Isaacs J; Hale G; Waldmann H; Compston A
    Brain; 1996 Feb; 119 ( Pt 1)():225-37. PubMed ID: 8624684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serology of demyelinating disease.
    Dowling P; Menonna J; Cook S
    Neurology; 1976 Jun; 26(6 PT 2):66-7. PubMed ID: 179032
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood proteins in multiple sclerosis].
    WENDER M; PATELSKI J; FILIPEK H
    Neurol Neurochir Psychiatr Pol; 1957; 7(6):913-22. PubMed ID: 13541576
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hematogenic picture in patients with multiple subacute and chronic sclerosis].
    TORRE M; SCARZELLA R; ZANALDA A
    Boll Soc Ital Biol Sper; 1953 Feb; 29(2):200-2. PubMed ID: 13081790
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute phase proteins in systemic lupus erythematosus].
    Marcinkowska-Pieta R; Mackiewicz A
    Pol Arch Med Wewn; 1987 Mar; 77(3):77-82. PubMed ID: 2484458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.